Citadel Advisors
ENTL icon

Citadel Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Citadel Advisors’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,367
Closed -$302K – 8768
2017
Q3 		$302K Buy
+16,367
New +$283K ﹤0.01% 6065
2017
Q2 		– Sell
-20,994
Closed -$290K – 8468
2017
Q1 		$290K Buy
+20,994
New +$337K ﹤0.01% 5928

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Citadel Advisors's ENTL Position: Q4 2017 in Review

Citadel Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 16,367 shares — an estimated $302K sold.

Citadel Advisors first reported a position in ENTL in Q1 2017 and held it in 2 quarters. The position peaked at $302K in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Citadel Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Citadel Advisors sold 16,367 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $302K.
  • Citadel Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Citadel Advisors's Entellus Medical, Inc. Common Stock position peaked at $302K in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.